SSY Group Limited (2005.HK)

HKD 3.31

(-2.93%)

Net Income Summary of SSY Group Limited

  • SSY Group Limited's latest annual net income in 2023 was 1.31 Billion HKD , up 17.44% from previous year.
  • SSY Group Limited's latest quarterly net income in 2024 Q2 was 685.73 Million HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported an annual net income of 1.12 Billion HKD in 2022, up 42.94% from previous year.
  • SSY Group Limited reported an annual net income of 785.53 Million HKD in 2021, up 28.36% from previous year.
  • SSY Group Limited reported a quarterly net income of 638.61 Million HKD for 2023 Q2, down 0.0% from previous quarter.
  • SSY Group Limited reported a quarterly net income of 680 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of SSY Group Limited (2023 - 2004)

Historical Annual Net Income of SSY Group Limited (2023 - 2004)

Year Net Income Net Income Growth
2023 1.31 Billion HKD 17.44%
2022 1.12 Billion HKD 42.94%
2021 785.53 Million HKD 28.36%
2020 611.97 Million HKD -46.13%
2019 1.13 Billion HKD 24.6%
2018 911.77 Million HKD 37.17%
2017 664.71 Million HKD 35.79%
2016 489.53 Million HKD 21.35%
2015 403.41 Million HKD -33.09%
2014 602.92 Million HKD 46.41%
2013 411.81 Million HKD 46.55%
2012 281 Million HKD 778.73%
2011 -41.4 Million HKD -115.89%
2010 260.59 Million HKD 20.59%
2009 216.09 Million HKD 111.64%
2008 102.1 Million HKD -17.55%
2007 123.83 Million HKD 32.99%
2006 93.11 Million HKD -16.83%
2005 111.96 Million HKD 9.37%
2004 102.36 Million HKD 0.0%

Peer Net Income Comparison of SSY Group Limited

Name Net Income Net Income Difference
Pak Fah Yeow International Limited 105.03 Million HKD -1155.358%
Grand Pharmaceutical Group Limited 1.87 Billion HKD 29.861%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 909.22%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 8686.976%
Qianhai Health Holdings Limited -52.7 Million HKD 2601.88%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -7796.85%
Essex Bio-Technology Limited 275.25 Million HKD -379.044%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 4671.702%
PuraPharm Corporation Limited -106.08 Million HKD 1343.027%
JBM (Healthcare) Limited 130.46 Million HKD -910.72%
Jacobson Pharma Corporation Limited 266.96 Million HKD -393.923%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 65.788%